Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Lupus & Connective Tissue Diseases Lupus & Connective Tissue Diseases for January/February 2020 Meta-Analysis Eyes Impact of Adherence to HCQ Among SLE Patients, Hypertensive Disorders of Pregnancy in SLE Contribute to Later CV Outcomes, Antimalarial Adherence is Important for Diabetes Prevention in Lupus, Big Data Breaks Down Sjögren’s Syndrome, Half of SLE patients have incident neuropsychiatric events, More must reads Lupus & Connective Tissue Diseases for November/December 2019 Hydroxychloroquine Prevents Congenital Heart Block Recurrence in Anti-Ro Pregnancies, VEDOSS Study Describes Predictors of Progression to Systemic Sclerosis, Repeat LTBI Testing Best in Patients Taking Biologics With New Risk Factors, TULIP Trials Show Clinical Benefit of Anifrolumab for SLE, Glucocorticoids Linked to Damage Accrual in SLE Regardless of Disease Activity, More must readsLupus & Connective Tissue Diseases for September/October 2019 Systemic Sclerosis Raises Risk of Breast Cancer, Lung Cancer, Melanoma, Expanding Medicaid Did Not Reduce Preventable Hospitalizations for Lupus Patients, Low disease activity a valid target in early SLE, investigators say, Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS, Zostavax Proves Safe, Effective in Patients With Nonactive SLE, More must readsLupus & Connective Tissue Diseases for July/August 2019 Rates of Giant Cell Arteritis Similar Among White and Black Patients, Repeated ANA Testing After Negative Result of Little Diagnostic Value, Tocilizumab Preserves Lung Function in Systemic Sclerosis, Genetic Variant Could Dictate Rituximab Response in Lupus, Routine Lung Disease Screening in Systemic Sclerosis, More must readsLupus & Connective Tissue Diseases for May/June 2019 Leflunomide added to glucocorticoids reduces relapse in IgG4-related disease, Pap Screen Gaps Abound in SLE Population, Antibody Hierarchy May Drive Development of SLE vs Antiphospholipid Syndrome, Elevated monocyte count predicts poor outcomes in idiopathic pulmonary fibrosis , Checkpoint inhibitor–induced rheumatic complications have unique features, More must readsPages« first 1 2 3 4 5 6 7 last »
